TOL

106.88

-0.08%↓

LZB

40.62

-1.36%↓

TOL

106.88

-0.08%↓

LZB

40.62

-1.36%↓

TOL

106.88

-0.08%↓

LZB

40.62

-1.36%↓

TOL

106.88

-0.08%↓

LZB

40.62

-1.36%↓

TOL

106.88

-0.08%↓

LZB

40.62

-1.36%↓

Search

AptarGroup

Closed

Sector Consumer cyclical

148.05 -1.62

Overview

Share price change

24h

Current

Min

146.83

Max

150.15

Key metrics

By Trading Economics

Income

826K

101M

Sales

-61M

848M

P/E

Sector Avg

27.228

36.052

EPS

1.52

Dividend yield

1.2

Profit margin

11.893

Employees

13,500

EBITDA

-16M

195M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+19.88 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.20%

3.07%

Next Earnings

1 May 2025

Next Dividend date

15 May 2025

Next Ex Dividend date

23 Apr 2025

Market Stats

By TradingEconomics

Market Cap

-355M

10B

Previous open

149.67

Previous close

148.05

News Sentiment

By Acuity

46%

54%

143 / 385 Consumer cyclical

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

AptarGroup Chart

Past performance is not a reliable indicator of future results.

Related News

11 Mar 2025, 23:16 UTC

Acquisitions, Mergers, Takeovers

Gray Media Gets FCC Waiver to Acquire KXLT-TV in Minnesota

11 Mar 2025, 21:17 UTC

Top News

Elon Musk Says Tesla to Double U.S. Vehicle Output Within Next Two Years

11 Mar 2025, 23:50 UTC

Market Talk

Gold Edges Higher Amid Global Economic Slowdown Fears -- Market Talk

11 Mar 2025, 23:43 UTC

Market Talk

Nikkei May Fall Amid Uncertainty over U.S.-Canada Trade Relations -- Market Talk

11 Mar 2025, 23:40 UTC

Top News

Trump, Hater of EVs, Says He's Buying a Tesla -- Update

11 Mar 2025, 23:32 UTC

Earnings

Genscript Biotech 2024 Adjusted Net $59.8M Vs. $58.1M >1548.HK

11 Mar 2025, 23:32 UTC

Earnings

Genscript Biotech: Net Supported Due to Recognition of Gain From Deconsolidation of Cell-Therapy Business >1548.HK

11 Mar 2025, 23:31 UTC

Earnings

Genscript Biotech 2024 Rev $594.0M Vs. $560.48M >1548.HK

11 Mar 2025, 23:31 UTC

Earnings

Genscript Biotech 2024 Net $2.86B Vs. Loss $355.12M >1548.HK

11 Mar 2025, 22:41 UTC

Top News

Trump, Hater of EVs, Says He's Buying a Tesla -- WSJ

11 Mar 2025, 22:21 UTC

Market Talk

Ramelius Keeps Bull After Mt Magnet Mine Plan Refresh -- Market Talk

11 Mar 2025, 21:51 UTC

Top News

House Passes GOP Measure to Avert Government Shutdown -- WSJ

11 Mar 2025, 21:45 UTC

Market Talk

Meridian Energy Offering Best Value in More Than a Year -- Market Talk

11 Mar 2025, 21:30 UTC

Market Talk

Nickel Industries Faces New Policy Headwind in Indonesia -- Market Talk

11 Mar 2025, 21:12 UTC

Top News

Trump Drops Threat to Double Tariffs on Canadian Steel and Aluminum -- WSJ

11 Mar 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

11 Mar 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

11 Mar 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

11 Mar 2025, 20:27 UTC

Top News

Dow Pares Losses While Canada, U.S. Discuss Trade Tensions -- WSJ

11 Mar 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

11 Mar 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk -2-

11 Mar 2025, 19:48 UTC

Top News

Trump Says He Will Raise Canada Steel and Aluminum Tariffs to 50% -- 4th Update

11 Mar 2025, 19:46 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

11 Mar 2025, 19:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

11 Mar 2025, 19:46 UTC

Market Talk

Canada Dollar Strengthens After Ontario Drops Power Surcharge -- Market Talk

11 Mar 2025, 19:33 UTC

Market Talk

U.S. Natural Gas Futures Relent a Little -- Market Talk

11 Mar 2025, 19:31 UTC

Market Talk

Oil Futures Hold Gains in Tariff-Driven Session -- Market Talk

11 Mar 2025, 18:45 UTC

Top News

Trump Says He Will Raise Canada Steel and Aluminum Tariffs to 50% -- 4th Update

11 Mar 2025, 18:39 UTC

Top News

U.S. Targets Small Currency Transactions to Fight Cartels -- WSJ

11 Mar 2025, 18:34 UTC

Market Talk

Gold Rises as Tariff Rhetoric Escalates -- Market Talk

Peer Comparison

Price change

AptarGroup Forecast

Price Target

By TipRanks

19.88% upside

12 Months Forecast

Average 180.5 USD  19.88%

High 205 USD

Low 160 USD

Based on 6 Wall Street analysts offering 12 month price targets forAptarGroup - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

145.61 / 151.15Support & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

143 / 385 Consumer cyclical

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AptarGroup

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.